Friday, February 23, 2007

from BBC News:

Drug 'cuts long-term cancer risk'
"Tamoxifen reduces the risk of breast cancer long after women stop taking the drug, research suggests."


from MD Anderson:

Gene Expression Test Reveals ER and HER-2 Status of Breast Tumors
"Two critical characteristics of breast cancer that are important to treatment can be identified by measuring gene expression in the tumor, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in Lancet Oncology online."


from CA: A Cancer Journal for Clinicians:

Preserving Primary Care: the Front Line in the War Against Cancer
"A recent report by the Commonwealth Fund meticulously documents that the US health care system delivers disturbingly low quality at a very high price.1 Many individuals struggle with obtaining adequate access to care. For both the general public and the cancer patient, lack of access impacts care delivery at every point along the spectrum—from prevention through treatment and end of life. Increasingly, spotlights are being focused on the root causes of this health care crisis, and new paradigms are emerging to address quality gaps. These include a focus on measuring and paying for quality as opposed to volume of care."